| ISIN | CH0011553598 |
|---|---|
| Valor Number | 1155359 |
| Bloomberg Global ID | BBG000GH31H0 |
| Fund Name | GENERALI Equity Fund Switzerland A |
| Fund Provider |
Generali Investments Schweiz AG
Soodmattenstrasse 2 8134 Adliswil 1 E-Mail: headoffice.ch@generali-invest.com Web: www.generali.ch/investments |
| Fund Provider | Generali Investments Schweiz AG |
| Representative in Switzerland | |
| Distributor(s) |
Generali Holding AG Adliswil Phone: +41 58 472 44 44 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | N/A |
| Peculiarities |
| Current Price * | 450.45 CHF | 19.01.2026 |
|---|---|---|
| Previous Price * | 455.22 CHF | 16.01.2026 |
| 52 Week High * | 456.73 CHF | 15.01.2026 |
| 52 Week Low * | 363.00 CHF | 09.04.2025 |
| NAV * | 450.45 CHF | 19.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 58,941,696 | |
| Unit/Share Assets *** | 58,889,669 | |
| Trading Information SIX | ||
| YTD Performance | +0.63% |
30.12.2025 - 19.01.2026
30.12.2025 19.01.2026 |
|---|---|---|
| 1 month | +1.28% |
19.12.2025 - 19.01.2026
19.12.2025 19.01.2026 |
| 3 months | +5.85% |
20.10.2025 - 19.01.2026
20.10.2025 19.01.2026 |
| 6 months | +9.19% |
21.07.2025 - 19.01.2026
21.07.2025 19.01.2026 |
| 1 year | +12.59% |
20.01.2025 - 19.01.2026
20.01.2025 19.01.2026 |
| 2 years | +23.44% |
19.01.2024 - 19.01.2026
19.01.2024 19.01.2026 |
| 3 years | +22.44% |
19.01.2023 - 19.01.2026
19.01.2023 19.01.2026 |
| 5 years | +29.99% |
19.01.2021 - 19.01.2026
19.01.2021 19.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 13.64% | |
|---|---|---|
| Novartis AG Registered Shares | 12.83% | |
| Nestle SA | 10.95% | |
| UBS Group AG Registered Shares | 6.27% | |
| Compagnie Financiere Richemont SA Class A | 5.25% | |
| Zurich Insurance Group AG | 5.21% | |
| ABB Ltd | 5.02% | |
| Sandoz Group AG Registered Shares | 2.89% | |
| Holcim Ltd | 2.77% | |
| Lonza Group Ltd | 2.74% | |
| Last data update | 31.12.2025 | |
| TER | 1.00% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |